Orion Biotech Opportunities - Warrants (15/04/2025) PEG Ratio

Orion Biotech Opportunities - Warrants (15/04/2025) (ORIAW) currently reports a PEG ratio of -1.58. That is above the sector sector average of -7.59. Use the charts on this page to explore Orion Biotech Opportunities - Warrants (15/04/2025)'s PEG ratio history and peer comparisons.

Orion Biotech Opportunities - Warrants (15/04/2025)'s PEG ratio of -1.58 is higher than the its sector sector average of -7.59. That is roughly 79.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Orion Biotech Opportunities - Warrants (15/04/2025)'s market price to a fundamental measure such as earnings, sales, or book value. At -1.58, ORIAW can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -1.58, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -7.59. From there, open related valuation or income-statement pages for Orion Biotech Opportunities - Warrants (15/04/2025), and consider following ORIAW for alerts when major investors trade the stock.